Clinical Trial Update: A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes [EARLY_Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study of HCR-188 in overweight or obese adults without type 2 diabetes has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• HCR-188

Snippet

Sponsor: Helicore Biopharma, Inc. | Conditions: Obesity and Overweight | EARLY_Phase 1 | Status: SUSPENDED